Dr. Andreas Neuffer

Experience

• 

  The Boston Consulting Group

  Jan 1994 - Jan 2001

  Principal

  • International strategy consulting projects for the construction, insurance, hospital, pharmaceutical and banking industry• Led a variety of strategy and operational projects, including the post-merger-integration of two major pharmaceutical companies (savings of >USD 1bn), due-diligences and strategy development for medical device companies, operational effectiveness in the construction industry (offer time reduction of >50%) as well as a product strategy for an insurance company (innovative offering in the German market)• Germany (5 years), US (2 years), Switzerland and Portugal (projects) Show less

• 

  Bain & Company

  Jan 2002 - Jan 2004

  Senior Principal

  • International strategy consulting projects for the chemical, insurance and pharmaceutical industry• Led projects including a comprehensive business unit review and business strategy development program for a major German chemical company, achieving savings of USD 200m p.a.

• 

  Novartis

  Jan 2004 - Jul 2023

  • Drove the short and long-term incentives strategy, governance and budget management for the entire company’s incentive budget of more than USD 1.3bn• Defined and aligned Compensation strategies, setting up KPI systems for short and long-term incentives, proposed appropriate Compensation levels for senior management and all associates• Translated the governance needs and expectations of various internal and external stakeholders (CEO, CFO, Head of the Board’s Compensation Committee, proxy advisors and investors) and shaped solutions accordingly Show less • Designed and developed the first Business Service unit for the company• Built an ‘internal start-up’ structure and team from scratch. Defined and developed specific services to be carved out and centralized in collaboration with future customers. Sold the services to customers who had the free choice between their old providers and the new set-up• Calculated achievable productivity and exceeded target by selling USD 100m of the services to company units in the first eighteen months saving up to 30% per service Show less

  • Global Head of Finance, Compensation

    Jan 2018 - Jul 2023

  • Global Head of Controlling, Vaccines Division

    Jan 2014 - Jan 2018

  • Head of Business Development, Global Business Services

    Jan 2012 - Jan 2014

  • Head of Controlling, Pharma Development

    Jan 2007 - Jan 2012

  • Head of Finance, Cardiovascular and Metabolism

    Jan 2006 - Jan 2007

  • Head of Strategic Planning, Emerging Markets

    Jan 2004 - Jan 2006
• 

  Self-employed

  Aug 2023 - now

  Consultant
• 

  Treazrly

  Jun 2024 - now

  Verwaltungsrat